US 7,563,798 B2
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
Timothy J. Guzi, Chatham, N.J. (US); Kamil Paruch, Garwood, N.J. (US); Michael P. Dwyer, Scotch Plains, N.J. (US); M. Arshad Siddiqui, Newton, Mass. (US); Panduranga Adulla P. Reddy, Walpole, Mass. (US); David B. Belanger, Cambridge, Mass. (US); Blake Hamann, Cambridge, Mass. (US); and Patrick J. Curran, Winthrop, Mass. (US)
Assigned to Schering Corporation, Kenilworth, N.J. (US)
Filed on Oct. 04, 2006, as Appl. No. 11/543,182.
Application 11/543182 is a continuation in part of application No. 11/244776, filed on Oct. 06, 2005, granted, now 7,196,092.
Application 11/244776 is a continuation in part of application No. 10/654157, filed on Sep. 03, 2003, granted, now 7,078,525.
Claims priority of provisional application 60/408030, filed on Sep. 04, 2002.
Prior Publication US 2007/0072882 A1, Mar. 29, 2007
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/519 (2006.01); C07D 487/04 (2006.01); A61P 35/04 (2006.01)
U.S. Cl. 514—259.3  [544/281] 3 Claims
 
1. A compound selected from the group consisting of the compounds of the formula:

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing
or a pharmaceutically acceptable salt thereof.